Personal information

No personal information available

Activities

Collapse all

Employment (1)

Hospital Pablo Tobon Uribe: Medellín, CO

2024-02-05 to present | Hematologist (Hematology)
Employment
Source: Self-asserted source
Jorge Lacouture-Fierro

Education and qualifications (3)

universidad CES: Medellín, Antioquia, CO

2017-06-01 to present | Especialista en Medicina Interna
Education
Source: Self-asserted source
Jorge Lacouture-Fierro

Universidad de Antioquia: Medellín, Antioquia, CO

2021-07-01 to 2023-07-31 | Hematologist (Hematology)
Education
Source: Self-asserted source
Jorge Lacouture-Fierro

Universidad Del Rosario: Bogota, CO

2008-06-01 to 2014-06-17 | Médico y cirujano
Education
Source: Self-asserted source
Jorge Lacouture-Fierro

Professional activities (2)

Hospital Universitario de San Vicente Fundación: Rionegro, ANTIOQUIA, CO

2023-08-08 to present | Hematologist (Hematology)
Membership
Source: Self-asserted source
Jorge Lacouture-Fierro

Universidad CES: Medellín, Antioquia, CO

2017-09-26 to present | Grupo de investigación de Especialidades Médico- Quirúrgicas
Membership
Source: Self-asserted source
Jorge Lacouture-Fierro

Works (9)

Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis

Colombia Medica
2023-11-30 | Journal article
DOI: 10.25100/cm.v54i3.5667
Contributors: Jorge Andrés Lacouture Fierro1; Daniel Andrés Daniel Andrés Ribero Vargas; Juanita Sánchez Cano; Lina Maria Gaviria Jaramillo; Oliver Gerardo Perilla Suarez; Kenny Mauricio Galvez Cárdenas; Sigifredo Ospina Ospina
Source: check_circle
Crossref

Amiloidosis AL: conceptos actuales

Medicina y Laboratorio
2022-04-04 | Journal article
DOI: 10.36384/01232576.572
Contributors: Jorge Andrés Lacouture-Fierro; Leonardo Mejía-Buriticá; Daniel Andrés Ribero-Vargas
Source: check_circle
Crossref

Síndrome antifosfolípido (SAF): diferencias clínicas e inmunoserológicas entre SAF primario y secundario en una cohorte colombiana

Revista Colombiana de Reumatología
2021-07 | Journal article
DOI: 10.1016/j.rcreu.2020.10.002
Part of ISSN: 0121-8123
Contributors: Jorge Lacouture-Fierro
Source: Self-asserted source
Jorge Lacouture-Fierro

AB0246 FACTORS ASSOCIATED WITH THE TIME OF PRESENTATION OF CARDIOVASCULAR EVENTS IN A COHORT OF COLOMBIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the Rheumatic Diseases
2020-06 | Conference poster
DOI: 10.1136/annrheumdis-2020-eular.6421
Part of ISSN: 0003-4967
Part of ISSN: 1468-2060
Contributors: Jorge Lacouture-Fierro
Source: Self-asserted source
Jorge Lacouture-Fierro

SAT0210 FACTORS ASSOCIATED WITH TIME TO SEVERE LUPUS NEPHRITIS IN A COHORT OF COLOMBIAN PATIENTS

Annals of the Rheumatic Diseases
2020-06 | Conference poster
DOI: 10.1136/annrheumdis-2020-eular.6282
Part of ISSN: 0003-4967
Part of ISSN: 1468-2060
Contributors: Jorge Lacouture-Fierro
Source: Self-asserted source
Jorge Lacouture-Fierro
grade
Preferred source (of 2)‎

Multiple Myeloma Mimicking a Small Vessel Vasculitis Presentation

Case Reports in Rheumatology
2020-02-12 | Journal article
DOI: 10.1155/2020/9146842
Part of ISSN: 2090-6889
Part of ISSN: 2090-6897
Source: Self-asserted source
Jorge Lacouture-Fierro

Clinical and Sociodemographic Factors Associated With Lupus Nephritis in Colombian Patients: A Cross-sectional Study

Reumatología Clínica
2019-11 | Journal article
DOI: 10.1016/j.reuma.2019.09.005
Part of ISSN: 1699-258X
Source: Self-asserted source
Jorge Lacouture-Fierro

298 Cardiovascular risk factors in a systemic lupus erythematosus cohort form colombia

Abstracts
2019-04 | Conference poster
DOI: 10.1136/lupus-2019-lsm.298
Contributors: Jorge Lacouture-Fierro
Source: Self-asserted source
Jorge Lacouture-Fierro

AB1320 Clinical, immunological and expositional factors in a colombian population with systemic lupus erythematosus associated with lupus nephritis

Epidemiology, risk factors for disease or disease progression
2018-06 | Conference poster
DOI: 10.1136/annrheumdis-2018-eular.5619
Contributors: Jorge Lacouture-Fierro
Source: Self-asserted source
Jorge Lacouture-Fierro
How many people are using ORCID?